A Phase 1a/B Study Of The Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors
This study is for the treatment of advanced solid tumors.
Study phase: I
Primary disease category: Cancer
Protocol number: EC1456
Projected enrollment dates: April 2016 to July 2017
Official study title: A PHASE 1A/B STUDY OF THE FOLIC ACID-TUBULYSIN CONJUGATE EC1456 IN PATIENTS WITH ADVANCED SOLID TUMORS